---
title: "KHPG: Injectable KH815 has received approval for clinical trials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236222141.md"
description: "KHPG announced that its wholly-owned subsidiary, KHPG Biotech, has received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical Products Administration for the clinical trial application of injectable KH815. Injectable KH815 is a novel dual-load antibody-drug conjugate independently developed by KHPG Biotech, which has potential anti-drug resistance targeting trophoblast cell surface antigen 2, indicated for advanced solid tumors"
datetime: "2025-04-16T11:34:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236222141.md)
  - [en](https://longbridge.com/en/news/236222141.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236222141.md)
generator: "portal-rs"
---

# KHPG: Injectable KH815 has received approval for clinical trials

KHPG announced that its wholly-owned subsidiary, KHPG Biotech, has received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration for the clinical trial application of injectable KH815. Injectable KH815 is a novel dual-load antibody-drug conjugate independently developed by KHPG Biotech, which has potential anti-resistance properties targeting trophoblast cell surface antigen 2, indicated for advanced solid tumors

### Related Stocks

- [002773.CN](https://longbridge.com/en/quote/002773.CN.md)

## Related News & Research

- [APTN Shareholders Approve Shift Toward Pharma and Biotech Trading](https://longbridge.com/en/news/298871061.md)
- [Merz wins respite in German municipal polls but tougher tests to come](https://longbridge.com/en/news/298898492.md)
- [Tigermed Directors Face Regulatory Warning and Fines Over Disclosure Lapses](https://longbridge.com/en/news/298755822.md)
- [10 Years of Growth and Innovation at Almac Pharma Services’ Charnwood](https://longbridge.com/en/news/299034116.md)
- [Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R) | TLTFF Stock News](https://longbridge.com/en/news/299039666.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**